Physician profile
Robert Parris
NPI 1043253511
$12,720.12
in general payments reported to CMS, 2019-2025
22 companies · $1,853 in 2025
The $1,853 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,010 · 2020: $225 · 2021: $314 · 2022: $3,153 · 2023: $5,574 · 2024: $592 · 2025: $1,853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,314 · Food and Beverage: $3,705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,313.52 |
| Food and Beverage | $3,704.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,964.92 | 2019-2025 | Watchman Access System, Emblem Mri S-Icd, Watchman |
| Medtronic, INC. | $3,671.14 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Micra |
| Abiomed | $1,379.13 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $647.07 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $430.05 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $363.06 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $315.82 | 2019-2025 | |
| Pfizer INC. | $177.75 | 2019-2025 | |
| Novo Nordisk INC | $171.59 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.24 | 2021-2023 | Jardiance |
| Abbott Laboratories | $123.89 | 2020-2023 | Cardiomems |
| Sanofi-Aventis U.S. LLC | $69.65 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $51.55 | 2019-2022 | |
| Amgen INC. | $41.65 | 2019 | |
| Philips North America LLC | $37.16 | 2022-2025 | Ecc Solutions |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $35.82 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Medtronic Vascular, INC. | $23.72 | 2019-2020 | |
| Irhythm Technologies, INC. | $22.58 | 2024 | Zio Xt Patch, Zio Monitor |
| Lantheus Medical Imaging, INC. | $17.04 | 2019 | |
| Merck Sharp & Dohme LLC | $16.15 | 2023 | Verquvo |
| Lundbeck LLC | $11.21 | 2019 | |
| Gilead Sciences, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Parris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.